In Brief: Biomatrix Synvisc
This article was originally published in The Gray Sheet
Biomatrix Synvisc: FDA's Orthopedic and Rehabilitation Devices Panel will review the injectable biopolymer at a Nov. 20 meeting, the company reports. Used to treat osteoarthritis of the knee, Synvisc currently is marketed in Canada by Rhone-Poulenc Rorer and in Sweden by Roche AB; the product also is approved in the European Economic Area, the company says...
You may also be interested in...
The maker of prestige-inspired cosmetics at value prices follows its TikTok viral success by teaming with Kathleen Belsten, aka Loserfruit, the second most-followed female gamer on the Amazon-owned livestreaming platform Twitch.
As distribution of Regeneron’s monoclonal antibody treatment for coronavirus begins, OWS officials worry about provider confusion with Lilly’s product due to differences in preparation and administration.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.